Clinical trials
Phase 1 Pulmonary Arterial Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
75 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 4 |
| 2013 | 7 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 11 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
| Terminated | 7 |
| Recruiting | 5 |
| Withdrawn | 4 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bial - Portela C S.A. | 10 |
| United Therapeutics | 8 |
| Merck Sharp & Dohme LLC | 4 |
| Humanis Saglık Anonim Sirketi | 3 |
| Pfizer | 3 |
| Pharmosa Biopharm Inc. | 3 |
| University of Minnesota | 3 |
| Vigonvita Life Sciences | 3 |
| Actelion | 2 |
| Aires Pharmaceuticals, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 75 |
| Hypertension, Pulmonary | 10 |
| Lung Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Erectile Dysfunction | 2 |
| Familial Primary Pulmonary Hypertension | 2 |
| Renal Insufficiency | 2 |
| Respiratory Tract Diseases | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Aneurysm | 1 |
Trials
Showing 26 to 50 of 75. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.